Evidence map›Paper›PMID 38499353›Full record

ArticleBMJ case reports2024

Male ductal carcinoma in situ: diagnosis and management of a rare disease in men.

Changtai Tian, Rosalinda Alvarado, Thomas Kim, Jessica Slostad

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Changtai TianInternal Medicine, Rush University Medical Center, Chicago, Illinois, USA changtai_tian@rush.edu.
Rosalinda AlvaradoInternal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
Thomas KimInternal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
Jessica SlostadInternal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
Rush University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ductal carcinoma in situ is very rare in male patients, accounting for approximately 5%-7% of all male breast cancers. We present a case of a man in his early 70s who presented with bloody nipple discharge and gynaecomastia and was subsequently diagnosed with ductal carcinoma in situ (DCIS). We discuss his management with surgical resection and the consideration of adjuvant treatment. We also review the existing literature on the presentation, diagnosis and management of DCIS in men.

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastCarcinoma in SituCarcinoma, Intraductal, NoninfiltratingGynecomastiaNipple DischargeAgedHumansMaleMastectomy, SegmentalRare DiseasesBreast cancerBreast surgeryOncologyScreening (oncology)

Identifiers

PMID38499353
PMCPMC10952870
OpenAlexW4392931654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.